Tethering Telomeric Double- and Single-stranded DNA-binding Proteins Inhibits Telomere Elongation by Etheridge, Katherine T. et al.
Tethering Telomeric Double- and Single-stranded
DNA-binding Proteins Inhibits Telomere Elongation*□S
Received for publication, October 22, 2007, and in revised form, January 2, 2008 Published, JBC Papers in Press, January 3, 2008, DOI 10.1074/jbc.M708711200
Katherine T. Etheridge‡, Sarah A. Compton§, Katharine S. Barrientos‡, Sezgin Ozgur§, Jack D. Griffith§,
and Christopher M. Counter‡1
From the ‡Department of Pharmacology and Cancer Biology, Department of Radiation Oncology, Duke University Medical Center,
Durham, North Carolina 27710 and §Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599
Mammalian telomeres are composed of G-rich repetitive
double-stranded (ds) DNAwith a 3 single-stranded (ss) over-
hang and associated proteins that together maintain chromo-
some end stability. Complete replication of telomeric DNA
requires de novo elongation of the ssDNA by the enzyme
telomerase, with telomeric proteins playing a key role in reg-
ulating telomerase-mediated telomere replication. In regards
to the protein component of mammalian telomeres, TRF1
and TRF2 bind to the dsDNA of telomeres, whereas POT1
binds to the ssDNA portion. These three proteins are linked
through either direct interactions or by the proteins TIN2
and TPP1. To determine the biological consequence of con-
necting telomeric dsDNA to ssDNA through a multiprotein
assembly, we compared the effect of expressing TRF1 and
POT1 in trans versus in cis in the form of a fusion of these two
proteins, on telomere length in telomerase-positive cells.
When expressed in trans these two proteins induced exten-
sive telomere elongation. Fusing TRF1 to POT1 abrogated
this effect, inducing mild telomere shortening, and generated
looped DNA structures, as assessed by electron microscopy,
consistent with the protein forming a complex with dsDNA
and ssDNA. We speculate that such a protein bridge between
dsDNA and ssDNAmay inhibit telomerase access, promoting
telomere shortening.
Telomeres are DNA-protein structures that cap and protect
the ends of eukaryotic chromosomes from illegitimate recom-
bination and degradation. In humans, the DNA portion of this
structure is composed of the G-rich sequence TTAGGG
repeated in tandem hundreds of times (1). This G-strand
extends beyond the complementary C-strand to form a ssDNA
overhang. Electron microscopy revealed that this ssDNA
extension appeared to invade the dsDNA,2 forming a D-loop,
with the intervening dsDNA looping out in what is termed a
T-loop. This structure has been speculated to impart some of
the replicative and protective functions of telomeres (2).
In terms of the protein components of telomeres, telomeric
DNA-binding proteins fall into two classes, ssDNA- or dsDNA-
binding proteins. In humans, the primary dsDNA telomere-
binding proteins are TRF1 (3) and TRF2 (4), whereas the prin-
ciple ssDNA-binding protein is POT1 (5). Disruption of TRF2
by expression of a dominant-negative version of the protein (6,
7) anddisruption of POT1 expression byRNAi or genetic knock
out (8–11) can lead to various degrees of chromosome instabil-
ity and/or cell arrest or death, whereas knock out of TRF1 is
embryonic lethal (12). On the other hand, overexpressing these
proteins alters telomere length (13–16). As access of telomer-
ase, the enzyme that elongates the G-strand overhang of
telomeres, to telomere ends is mediated by proteins in lower
eukaryotes as a means of regulating telomere length; human
telomere-binding proteins may also serve in this capacity (17).
Thus, telomere-binding proteins can function in telomere sta-
bility and/or telomerase-mediated replication of telomeres.
Accumulating evidence argues that the ssDNA- and dsDNA-
telomere-binding proteins form a complex. TRF1 andTRF2 are
known to bind the protein TIN2, and TIN2 has been found to
associate with another protein, TPP1, which in turn can bind to
POT1 (9, 18–23). TRF2 may also associate with POT1 (9, 22).
The association of these proteins has been speculated to form a
protein-bridge at telomeres in which the dsDNA-binding pro-
teins, TRF1 and TRF2, unite with the ssDNA-binding protein,
POT1 (24).
The function of such a bridge remains to be fully elucidated
but could very well be involved in telomere stability and repli-
cation. Although loss-of-function analysis has been an inform-
ativemeans to explore the role of the various components of the
large telomere protein complex, each of these proteins bind to
many other proteins. Hence the loss of any one protein may
have a multitude of effects (23). We therefore employed gain-
of-function analysis to determine the biological consequence of
connecting ds- to ss-telomeric DNA through a multiprotein
assembly. Specifically, we compared the effect expressing TRF1
and POT1 in trans on telomere length in telomerase-positive
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cells versus in ciswhereby these two proteins are forced to con-
stitutively interact via a direct fusion.
EXPERIMENTAL PROCEDURES
Constructs—The POT1-TRF1 fusion protein was created by
inserting POT1 in framewith FLAG-TRF1 into pBabepuro (25)
using a standard PCR approach. The POT1-FLAG-TRF1
cDNA was liberated by digesting with BamHI and SalI and
inserted into the same sites of pBluescriptIIKS (Stratagene) for
in vitro transcription and translation. The POT1-FLAG-TRF1
cDNA was PCR amplified, verified by direct sequencing, then
blunt end ligated into the StuI site in pFastBac (Invitrogen) to
make the transfer vector for bacmid preparation. pBabehygro-
FLAG-TRF1 was created by subcloning FLAG-TRF1 from
pcDNA3-FLAG-TRF1 into the EcoRI/SalI sites of pBabehygro
(25). pBabepuro-FLAG-POT1, pCIneo-FLAG-POT1, pCIneo-
FLAG-POT1OB, and pEYFP-N1-Myc-TRF2 are described
previously (15, 26).
Cell Culture—293T cells were stably infected with retrovi-
ruses derived from the above described pBabe plasmids and
were selected with 1.0 g/ml puromycin (Sigma) or 100 g/ml
hygromycin-B (Sigma) 48 h post-infection, as described previ-
ously (27). The first confluent plate after infection was arbi-
trarily assigned as population doubling 0. Following selection,
cells were split, and colonies were picked to establish mono-
clonal cell lines.
Immunofluorescence—293T cells seeded on coverslips were
transiently co-transfected with 0.9 g of pBabepuro-POT1-
FLAG-TRF1 and 0.1g of YFP-TRF2with the FuGENE6 reagent
as per the manufacture’s protocol (Roche). 48 h later, cells were
fixedwith 3.7% formaldyhyde in 1PBS for 10min, washed twice
with 1 PBS, permeabilized with 0.5% Triton X-100 in 1 PBS,
washed twice with 1 PBS, and blocked with blocking buffer (1
PBS,0.2%cold fishgelatin,0.5%bovineserumalbumin) for30min.
The POT1-FLAG-TRF1 fusion protein was detected by incubat-
ing with anti-FLAG M2 antibody (Sigma) at a 1:5000 dilution in
PBGfor1handrecognizedby incubatingwithdonkeyanti-mouse
antibody conjugated with rhodamine RedX (Jackson ImmunoRe-
search Laboratories) diluted 1:200 in blocking buffer for 45 min.
Following three 5-minwasheswith blocking buffer and two5-min
washeswith1PBS, coverslipsweremounted in faramountaque-
ous mounting medium. pEYFP-N1-Myc-TRF2 was visualized by
virtue of its fluorescence. Cellswere examined at630magnifica-
tion on anOlympus IX70 confocal fluorescent microscope.
G-strand and Double-strand Telomeric DNA Binding Assays—
35S-labeled proteins were synthesized in vitro by the T7
quick-coupled TNT system (Promega) using the plas-
mids pCIneo-FLAG-POT1, pCIneo-FLAG-POT1OB, pRC-
CMV-FLAG-TRF1, or pBluescriptIIKS-POT1-FLAG-TRF1
following the manufacturer’s instructions. One-fifth of the
reaction was removed to be used as an input control, and the
remaining reaction mixture was diluted in 1 PBS supple-
mented with 0.1 mM phenylmethylsulfonyl fluoride and incu-
batedwith anti-FLAGM2-agarose affinity gel for 1 h. Resin was
washed three times in 1 PBS for 5 min, and one-third of the
immunoprecipitate was incubated for 30 min in binding buffer
(50 mM NaCl, 25 mM Hepes, pH 7.4, 2.5 M PBoli109 primer
5-CCGTAAGCATTTCATTATTGGAATTCGAGCTCGT-
TTTCGA, 1 mM EDTA, pH 8.0, 100 ng/l bovine serum albu-
min) containing 10 nM G-strand oligonucleotide (T2AG3)5 or
10 nM 0.8 kbp double-stranded telomeric repeat DNA frag-
ment, which was 32P-labeled with T4 polynucleotide kinase
(Invitrogen) according to the manufacturer’s protocol and
purified from unincorporated 32P with G-25 gel filtration mini
spin columns (Promega) according to the manufacturer’s pro-
tocol. Unbound ss- or ds-telomeric repeat DNA was removed
bywashing the anti-FLAGM2 resin three times in 1 PBS for 5
min. Resin was resuspended in 1 SDS loading buffer, boiled
for 10 min, and separated by electrophoresis on a SDS-PAGE
gel. The gel was incubated in fixing solution (40% MeOH, 7%
acetic acid, 10%glycerol) and dried. Productswere visualized by
exposure to a phosphorimager screen and quantified using
ImageQuant version 1.0 (GE Healthcare).
Chromatin Immunoprecipitation Assay—Chromatin immu-
noprecipitations were performed as described previously (28)
with the following modifications: a Branson sonifier microtip
(Branson Ultrasonics) was used for sonification (output 3; duty
cycle 30% for five 10 sec bursts), afterwhich insolublematerialwas
pelleted bymicrocentrifugation (13,000 g for 5min at 4 °C), and
the remaining lysate was diluted in lysis buffer (1:2). 30 l of 50%
slurry of GammaBind G-Sepharose (Amersham Biosciences) was
added to the lysate and incubated at 4 °C for 1 h to preclear the
lysate. The lysate was then transferred to new tubes and immuno-
precipitated overnight with anti-FLAG M2-agarose affinity gel
(Sigma). Finally, dot blots were hybridized with a 32P-labeled oli-
gonulceotide telomeric probe (T2AG3)4 in Church’s buffer over-
night at 50 °C followed by two washes with 4 SSC containing
0.1% SDS. After 5 days of phosphorimaging, the blots were
stripped andprobedwithanAluDNArepeatprobe (29) inChurch’s
buffer overnight at 42 °C followedby twowasheswith 2SSC for 15
min each and twowasheswith 0.1SSCcontaining 0.1%SDS for 10
min each. Hybridization of the probes was confirmed with 10 g of
total genomicDNAblotted on eachmembrane.
TelomereLengthMeasurements—Telomere-containing restric-
tion fragments were visualized by resolving 10 g of genomic
DNA digested with HinfI and RsaI on 0.5% agarose gels, which
were hybridized with a 32P-labeled (CCCTAA)3 probe followed
by three washes in 15 SSC and exposed to a phosphorimager
screen as described previously (30). Telomere lengths were
recorded as themodal (peak) signals of the telomere-containing
fragments using ImageQuant version 1.0.
Immunoprecipitations and Immunoblottings—Two 10-cm
plates of the 293T cell lines were lysed in lysis buffer (1 PBS, 5
mM EDTA, 0.2%Nonidet P-40, 10% glycerol, 1 g/ml pepstatin
A, 1g/ml leupeptin, 1.5g/ml aprotinin, 0.1mMphenylmeth-
ylsulfonyl fluoride, and 1 mM Na3VO4). Equal amounts of sol-
uble lysatewere incubatedwith 10l of anti-FLAGM2-agarose
gel (Sigma) diluted in 100l of lysis buffer at room temperature
for 1 h. Resin was washed twice in lysis buffer for 5 min, resus-
pended in 1 SDS loading dye, boiled for 10 min, resolved on
SDS-PAGE gels, and immunoblotted with the anti-FLAG anti-
body as described previously (31).
Protein Purification—The fusion construct POT1-FLAG-
TRF1 was cloned into pFastBac1 vector. The FLAG tag was
positioned between the two genes. The integrity of the fusion
gene was analyzed by DNA sequencing. The baculovirus was
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prepared in Sf21 cells (Invitrogen) according to the manufac-
turer’s procedures. After second amplification in SF21 cells, the
virus had a titer of 1  109 plaque-forming unit/ml. For puri-
fication of the fusion protein, approximately 300 ml of SF21
cells grown in suspension in Grace’s Media (Invitrogen) with
10% fetal bovine serum (Sigma) were inoculated with virus at
multiplicity of infection (m.o.i.)  10. After further 48-h incu-
bation at 27 °C, the cells were collected by spinning at 2000 rpm
for 10 min. The cell pellet was washed once with ice-cold 1
PBS, frozen, and kept at80 °C till further use. The purification
protocol was performed as recommended by the manufacturer
(Sigma). Briefly, the cells were lysed in buffer A (50 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40).
After 30-min incubation on ice, the lysate was Dounce homog-
enized, sonicated, and kept on ice for 10 min more. The lysate
was clarified by centrifugation at 15,000  rpm for 30 min at
4 °C in a Sorvall SS34 rotor. 0.5 ml of pre-equilibrated with
buffer A FLAG resin (Sigma) was added to the clarified extract.
The purificationwas done as batch purification. After 2-h incu-
bation with the resin, the resin was washed five times with
Buffer A containing 300 mM NaCl. The bound protein was
eluted with FLAG peptide according to manufacturer’s recom-
mendations. The purity of the protein was analyzed by SDS-
PAGE and Coomassie blue staining. The POT1-FLAG-TRF1
protein was stored in aliquots at80 °C in buffer containing 50
mM Tris-HCl, pH 7.4, 300 mM NaCl, and 5% glycerol.
Electron Microscopy—Model telomere templates were gen-
erated as described previously (32). Briefly, pRST5 plasmid
containing3 kb of non-telomeric DNA and a 500 bp region of
telomeric repeat was linearized using BSMBI restriction site
such that the 500 bp telomeric repeat tract was positioned at
one end of the linearized molecule. A 54 nucleotide single-
stranded overhang was created by ligation of a 58 nucleotide
telomeric oligonucleotide onto the telomeric end. The model
telomere templates were incubated in a reaction with 100 ng
each of TRF1 and POT1-TRF1 for 30 min on ice, in buffer
containing 20 mM HEPES, 80 mM KCl, 0.5 mM dithiothreitol,
0.1 mM EDTA. Samples were fixed with 0.6% glutaraldehyde,
and protein-DNA complexes were isolated over a 2.5-ml Bio-
Gel A 15M column and incubated with spermidine before they
were directly adsorbed to glow-charged carbon foil grids, dehy-
drated by a series of water and ethanol washes and rotary
shadow cast with tungsten. Images were collected using an FEI
Tecnai 12 electron microscope and Gatan Ultrascan US400SP
digital camera with Gatan Digital Micrograph software.
RESULTS AND DISCUSSION
The POT1-TRF1 Fusion Protein Exhibits Telomeric dsDNA
and ssDNA Binding Activities—Large complexes containing
both the telomeric ssDNA-binding protein POT1 and telo-
meric dsDNA-binding proteins TRF1 and TRF2 have been iso-
lated from mammalian cells (20, 22), although the biological
importance of combining these two different DNA-binding
activities in one complex is unclear. To this end, we used a
gain-of-function approach to determine the effect on telomere
length in telomerase-positive cells upon physically tethering
the telomeric ssDNA-binding protein POT1 to the telomeric
dsDNA-binding proteinTRF1, such that the telomeric dsDNA-
and ssDNA-binding activities would be constitutively united,
compared with expressing TRF1 and POT1 in trans.
To begin this analysis, we first created a POT1-TRF1
telomere chimeric protein by fusing the human POT1 cDNA
in-frame to the N terminus of human TRF1, with the FLAG
epitope sequence acting as a linker peptide between the two
proteins. In this configuration, the DNA-binding domains of
both proteins were at the extreme termini of the fusion protein
to minimize negative effects on their activity (Fig. 1A).
We next tested whether the fusion protein retained the abil-
ity to bind telomeric dsDNAand ssDNA in vitro. Specifically, to
test for ss-telomere binding, 35S-labeled recombinant POT1-
TRF1 fusion protein was generated in rabbit reticulocyte lysate
in vitro and incubated with a 32P-labeled G-strand telomere
oligonucleotide. The fusion protein was immunoprecipitated
by virtue of the FLAG epitope tag and resolved by SDS-PAGE
followed by exposure to film to visualize the labeled protein and
DNA, as described previously (5, 15). As negative controls we
similarly assayed a POT1 protein lacking one of the telomeric
ssDNA-binding OB-fold domains (POT1OB) and wild-type
TRF1 (that binds telomeric dsDNA and not ssDNA) and as a
positive control, POT1. As expected, the positive-control
POT1 co-immunoprecipitated with the telomeric oligonucleo-
tide. Similarly, although the fusion protein was expressed at
lower levels, it clearly co-immunoprecipitated with telomeric
ssDNA. This association depended upon the DNA-binding
activity of POT1, as neither the POT1OB nor the TRF1 pro-
tein co-immunoprecipitated with the same DNA (Fig. 1B).
Thus, the fusion protein bound telomeric ssDNA in vitro.
To determine whether the fusion protein retained the ability
to bind telomeric dsDNA, POT1-TRF1, positive control TRF1,
or negative control POT1 (that binds only telomeric ssDNA),
35S-labeled recombinant proteins were mixed with 32P-labeled
telomeric dsDNA, immunoprecipitated, and resolved by SDS-
PAGE, akin to the method used to monitor POT1 binding to
telomeric ssDNA. Positive-control TRF1 and the fusion protein
both co-immunoprecipitated with the telomeric dsDNA,
whereas negative control POT1 protein did not. Thus, the
fusion protein can also bind telomeric dsDNA in vitro (Fig. 1C).
The presence of truncated products that could also bind DNA
precluded determining the degree that the full-length fusion
protein associatedwithDNA.Taken together, we conclude that
the fusion protein retained the ability to bind both telomeric
ssDNA and dsDNA in vitro.
The POT1-TRF1 Fusion Protein Localizes to Telomeres in
Vivo—We next extended these results in vivo by assaying
whether this fusion protein could also localize to the nucleus
and associate with telomeres. POT1-TRF1 was transiently co-
expressed in 293T cells with a YPF-tagged version of the
telomere-binding protein TRF2 to mark telomeres (4). POT1-
TRF1, as detected by immunofluorescence via the FLAG
epitope, formed punctate staining within the nucleus. YFP-
TRF2 similarly formed nuclear foci indicative of telomeres, as
detected via the fluorescence of YPF, and these foci co-localized
with POT1-TRF1 (Fig. 1D). Telomeric DNA association with
POT1-TRF1 was verified by an independent in vivo assay,
namely chromatin immunoprecipitation. Specifically, the
fusion protein co-immunoprecipitated with telomeric DNA, as
POT1-TRF1 Inhibits Telomere Elongation
MARCH 14, 2008 • VOLUME 283 • NUMBER 11 JOURNAL OF BIOLOGICAL CHEMISTRY 6937
assessed with a telomeric DNA probe, andmoreover, this asso-
ciation was abolished if DNA and protein were not cross-
linked. The fusion protein bound specifically to telomeric
DNA, and not irrelevant DNA (detected with an Alu DNA
probe), and to a similar level as positive control POT1 andTRF1
proteins (Fig. 1E). Taken together, these data argue that the
fusion protein is able to associate with telomeres in vivo.
The POT1-TRF1 Fusion Protein Induces Lariat DNA
Structures—To explore the effect of expressing POT1-TRF1 on
telomericDNAstructure, the fusionproteinwas highly purified
from insect cells (Fig. 2B) and incubatedwith telomeric DNA in
a 1:1 ratio with purified TRF1.We included TRF1 in these reac-
tions because this protein must dimerize to bind telomeric
DNA, and in cells endogenous TRF1 presumably complexed
with the fusion protein (3, 33). Indeed, TRF1was found to foster
the binding of the fusion protein to telomeric dsDNA (not
shown). Themodel telomere substrate was composed of 3 kb
of non-telomeric DNA ending in 500 bp of telomeric dsDNA
with a 54 nucleotide 3 overhang.
Three types of DNA-protein complexes were noted. First,
consistent with the ssDNA-binding activity of POT1 (5),
47.8%  11.1 of the DNA-protein complexes had protein at
the end (ssDNA) of the substrate. Second, consistent with
the known dsDNA-binding activity of TRF1 (3, 33), 15% 
3.3 of the DNA-protein complexes had protein bound inter-
nally within the 500 bp telomeric dsDNA region of the
substrate.
Third andmost interesting, 12.8%  4.4 of the DNA-protein
complexeswere characterized by a protein complex at the junc-
tion of a lariatDNAstructure. This latter structurewas depend-
FIGURE 1. POT1-TRF1 binds to telomeres. A, scale diagram of the POT1-TRF1 fusion protein. OB1 and OB2, oligonucleotide/oligosaccharide binding (OB)-fold
telomeric ssDNA-binding domains; FLAG, FLAG epitope tag used as a linker; acidic, acidic domain, dimerization; TRF1, dimerization domain; myb, myb-type
DNA binding motif. B and C, POT1-TRF1 fusion protein binds telomeric DNA in vitro. Immunoprecipitation of in vitro produced 35S-labeled FLAG-tagged
proteins incubated with 32P-labeled G-strand oligonucleotide (B) or 32P-labeled telomeric dsDNA fragment (C). Bottom panel, binding of DNA relative to protein
expression. D, POT1-TRF1 fusion protein co-localizes with the telomere-binding protein TRF2. An example of 293T cells transiently co-expressing YFP-TRF2 and
POT1- TRF1 stained with an -FLAG antibody to detect the POT1-TRF1 fusion protein (left panel), viewed as a fluorescence image to detect YFP-TRF2 (middle
panel), or a merge of both images (right panel). E, 293T cells stably expressing FLAG-POT1, FLAG-TRF1, FLAG-POT1-TRF1, or empty pBabe vector were treated
with formaldehyde to cross-link proteins and DNA or left untreated as a control. The cells were then subjected to chromatin immunoprecipitation with
-FLAG-agarose affinity gel followed by Southern blotting with a telomeric probe. As a control, membranes were also stripped and re-hybridized with an Alu
probe to determine nonspecific DNA interactions. Hybridization of the probes was confirmed using genomic DNA.
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ent upon the telomeric ssDNA. Specifically, when the experi-
ment was repeated using a similar model telomere substrate
composed of 500 bp of telomeric dsDNA, but lacking the 3
overhang, there was a shift in the complexes from those with
protein at the end or in a lariat, to almost exclusively complexes
with protein bound within the telomere repeat tract (Fig. 2, A
and C). These results were highly reproducible, as they were
generated from three independent experiments in which over
560 molecules were scored. TRF1 alone does not induce these
structures (2). POT1 could not be purified to similarly test, and
hence it is formally possible that POT1 alone may induce such
structures. Arguing against this possibility is the fact that POT1
binds only ssDNA (Ref. 5 and Fig. 1,A and C), but the loops are
presumably a union of dsDNA and ssDNA because of their
large size. Taken together, we suggest that either the fusion
protein tethers both dsDNA and ssDNA together, looping out
the intermediate DNA, or that this protein complex stabilizes
the structure formed when the ssDNA invades the dsDNA and
again loops out the intervening DNA (2). In either scenario, the
fusion protein fosters a complex composed of telomeric
dsDNA and ssDNA.
Expression of POT1 and TRF1 in cis versus in trans Causes
Opposite Effects on Telomere Length—Given that the fusion
protein retained theDNA-binding activities of POT1 andTRF1
and could foster the union of telomeric dsDNA and ssDNA, we
next addressed what effect expression of POT1 and TRF1 in
trans versus in cis in the form of a fusion protein would have on
telomere length in telomerase-positive cells. The virally trans-
formed cell line 293T, a subline of
the telomerase-positive cell line 293
(30), was stably infected with a ret-
rovirus encoding the POT1 and
TRF1, POT1-TRF1, or no transgene
(vector). Previously it had been
shown that clonal populations
could serve as a better indicator
than polyclonal populations of the
variability on telomere length when
overexpressing a telomere-binding
protein (16). Therefore, we picked
and cultured 13 clones from cells
expressing POT1 andTRF1 in trans,
14 clones expressing these proteins
in cis (POT1-TRF1), and 12 clones
from vector cells (Fig. 3, A–C), con-
firmed expression of the indicated
proteins by immunoblot analysis
(Fig. 3, D–F), and measured their
telomere length by Southern
hybridization after an average of
35–40 population doublings.
As previously reported, telomere
length can vary in clonal popula-
tions expressing telomere-binding
proteins (16), and indeed this was
observed in all the clones (Fig. 3,
A–C) and also polyclonal popula-
tions (supplemental Fig. 1 and not
shown) from the three different genotypes. This variation was
apparently not a product of differential ectopic expression of
POT1, TRF1, the fusion POT1-TRF1 protein, or a truncated
version thereof (Fig. 3, E and F). Despite this variability, co-
expression of POT1 and TRF1 in trans promoted telomere
elongation. Specifically, the average modal telomere length of
the 13 clones expressing POT1 and TRF1 in transwas 12.7 kbp,
with some clones having an average telomere length as high as
17.2 kbp (Fig. 3B). On the other hand, the modal telomere
length of vector cells ranged from4.5 to 8.7 kbp,with an average
length of the 12 clones being 6.9 kbp (Fig. 3A). Similar results
were found also with polyclonal populations (supplemental Fig.
1). Thus, telomeres were elongated by an average of 5.3 kbp in
cells expressing POT1 and TRF1 in trans.
In contrast, cells in which POT1 and TRF1 were engineered
to constitutively interact via a direct fusion had an average
telomere length of 6.2 kbp (Fig. 3C), a full 6.5 kbp shorter on
average than when POT1 and TRF1 were expressed in trans
(Fig. 3B). Although there was again telomere length heteroge-
neity among the 14 clones (Fig. 3C) as well as polyclonal popu-
lations (supplemental Fig. 1 and not shown) expressing POT1
and TRF1 in cis, all these clonal and polyclonal populations had
telomeres shorter than the average telomere length of cells
expressing these proteins in trans, with the most extreme dif-
ference being 15.9 kbp between the two genotypes. The fusion
protein not only negated the effect of overexpressing POT1 and
TRF1, it also inducedmild telomere shortening compared with
vector-infected cells. Cells expressing the fusion protein had an
FIGURE 2. In Vitro binding and remodeling of synthetic telomeres by co-incubation of purified TRF1-
POT1 fusion protein and TRF1. The TRF1-POT1 fusion protein and TRF1 were purified in insect cells and
co-incubated with model telomeres according to the conditions in the text. Protein-DNA complexes were
fixed, isolated over an A5M BioGel column, followed by adsorption onto glow-charged copper grids and
rotary shadowcast with tungsten. Images are shown in reverse contrast. A, top panel, examples of mole-
cules generated on model telomeres 500 bp ending in a 54 nucleotide single-stranded overhang of
TTAGGG. Bottom panel, model telomeres 500 bp were generated with or without the 54 nucleotide over-
hang and incubated with both the TRF1-POT1 fusion protein and TRF1. DNA molecules were classified as
unbound, protein-bound at one end, proteins internally bound along the telomere tract, or arranged into
loops. More than 560 molecules were scored in three independent experiments, and the percentage of
molecules in each category was determined. Values represent the average number of molecules in each
category  S.E. B, higher magnification of loops formed by TRF1-POT1 fusion protein and TRF1 on model
telomeres 500 bp.
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average telomere length almost 1 kbp shorter than vector cells,
reflecting the observation that two thirds of the clones had
telomeres shorter than vector cells. Moreover, vector cells (Fig.
3A) never exhibited telomeres as short (2.3 kbp) as those seen in
the fusion-expressing cells (Fig. 3C).
Summary—To explore the biological consequence of a com-
plex containing both telomeric dsDNA- and ssDNA-binding
proteins, we compared the effect on telomere length of express-
ing POT1 and TRF1 in trans versus in cis via a direct fusion of
these proteins to generate a chimeric protein capable of binding
telomeric dsDNA and ssDNA in vitro. We report that in trans
these proteins induced extensive telomere elongation, whereas
in cis this effect was abrogated, and if anything, led to telomere
shortening in many of the clones. Not all clones exhibited as
dramatic difference in length, consistent with the previous
observation that complex telomere patterns are seen when
POT1 or other telomere-binding proteins are overexpressed
(14, 16). Although a number of mechanisms by which this
fusion proteinmay act oppositely comparedwith co-expression
of TRF1 and POT1 are possible, including fusion of these pro-
teins inhibiting some function of TRF1 or POT1 aside from
DNA binding, some insight was provided by electron micro-
scopic analysis of complexes formed with the fusion protein
and a telomeric substrate. This protein fostered the produc-
tion or stabilization of lariat structures, in which dsDNA and
ssDNA formed a complex with the proteins. We speculate
that such a structure may resist access of telomerase and
correspondingly may promote the telomere shortening
observed in cells. In support of this model, knocking down
the expression of some proteins in the telomeric complex
has been reported to cause the opposite phenotype to fusing
the telomere proteins, namely telomere elongation (24). Col-
lectively, these data support a model whereby a complex
between telomeric dsDNA- and ssDNA-binding proteins
negatively regulate telomere length.
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